Market Overview:
The global nanoemulsion market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising demand for novel drug delivery systems, and growing investments by pharmaceutical companies in R&D activities. Based on type, the global nanoemulsion market is segmented into steroids, anesthetics, NSAIDs (non-steroidal anti-inflammatory drugs), immunosuppressants, antiretrovirals, antimicrobials, and vasodilators. Among these segments, the NSAIDs segment is expected to account for the largest share of the global nanoemulsion market in 2018. This can be attributed to factors such as rising incidence of pain disorders and increasing use of NSAIDs for pain relief. Based on application, the global nanoemulsion market is segmented into hospital pharmacies; retail pharmacies; and e-commerce.
Product Definition:
A nanoemulsion is a stable dispersion of one or more immiscible liquids, in which small droplets of one liquid are suspended throughout another liquid. Nanoemulsions have been found to be very important in pharmaceuticals, cosmetics and food science.
Steroids:
Steroids are organic compounds derived from cholesterol. They are used in the form of prescribed by doctors for various medical conditions such as rheumatoid arthritis, asthma, diabetes, etc. Steroids can also be obtained through a illegal route (performance-enhancing drugs) which is not recommended by doctors and has adverse effects on health.
Anesthetics:
Anesthetics is a class of drugs that reduces the awareness and consciousness of a person. They are used to put people into an artificial sleep so that they do not feel any pain. The most commonly used anesthetics include etomidate, propofol, and thiopental. Anesthesia is mainly used for surgical procedures but it can also be administered during dental treatments as well as while undergoing diagnostic or therapeutic procedures like biopsy or MRI scans.
Application Insights:
The market is categorized on the basis of application into hospital pharmacies, retail pharmacies, and e-commerce. The e-commerce segment held the largest share in 2017 owing to increasing demand for these products from various countries such as India, China, Australia and New Zealand. Nanoemulsions are used for a variety of applications including drug delivery systems in ophthalmic solutions (eye drops), oral pharmaceuticals/nutraceuticals (tablets & liquids), skin care creams & lotions, shampoos & conditioners and others such as food additives or flavors enhancers.
Nanoemulsion drugs can be used to deliver proteins that have been shown to reduce inflammation by modulating cytokine production by immune cells. This factor is anticipated to increase product demand over the forecast period due to its ability of reducing inflammation at a molecular level without causing any harm or side effects on body organs or systems.
Regional Analysis:
Asia Pacific is expected to be the fastest-growing regional market with a CAGR of XX% over the forecast period. The growth can be attributed to rising product demand in China and India owing to increasing aging population, high prevalence of chronic diseases, and growing healthcare expenditure in these countries. In addition, increasing number of retail pharmacies due to economic reforms in these countries will drive the demand further. For instance, according to IMS Health data published on 23rd April 2017, around 6 million people used internet for purchasing medicines in China as compared 5 million users from 2016 which indicates an increase of 10%.
In addition it has been observed that online medicine sales have increased by 20% since 2015 which also indicates a positive outlook for this industry over the next few years.
Growth Factors:
- Increasing demand for better drug delivery systems: The nanoemulsion market is expected to grow at a high rate due to the increasing demand for better drug delivery systems. Nanoemulsions are an efficient and versatile way of delivering drugs and have been found to be more effective than other conventional methods. This is driving the growth of the nanoemulsion market.
- Growing research and development activities: The nanoemulsion market is also expected to grow due to the growing research and development activities in this field. A large number of companies are investing in R&D in order to develop new products that can be used in various applications such as cosmetics, food, pharmaceuticals, etc. This is driving the growth of the nanoemulsion market.
- Rising awareness about benefits of using nanoemulsions: There has been a rise in awareness about the benefits of using nanoemulsions among consumers across different industries such as pharmaceuticals, cosmetics, food & beverages, etc., which is helping fuel the growth of this market segmentation significantly .This trend will continue over next few years owing Nano-sized droplets dispersed uniformly with no agglomerates formation ability that helps active ingredients penetrate deep into skin layers or any targeted site quickly without losing their bioavailability properties..
Scope Of The Report
Report Attributes
Report Details
Report Title
Nanoemulsion Market Research Report
By Type
Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials, Vasodilators, Others
By Application
Hospital Pharmacies, Retail Pharmacies, E-commerce
By Companies
Allergan plc, AbbVie Inc., AstraZeneca Inc., Fresenius Kabi AG, Kaken Pharmaceutical Co., Ltd., GlaxoSmithKline plc, Novartis AG, Sanofi, B. Braun Melsungen AG.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Nanoemulsion Market Report Segments:
The global Nanoemulsion market is segmented on the basis of:
Types
Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials, Vasodilators, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, E-commerce
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan plc
- AbbVie Inc.
- AstraZeneca Inc.
- Fresenius Kabi AG
- Kaken Pharmaceutical Co., Ltd.
- GlaxoSmithKline plc
- Novartis AG
- Sanofi
- B. Braun Melsungen AG.
Highlights of The Nanoemulsion Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Steroids
- Anesthetics
- NSAIDs
- Immunosuppressant
- Antiretroviral
- Antimicrobials
- Vasodilators
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- E-commerce
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nanoemulsion Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nanoemulsion is a type of water-in-oil emulsion. It is a mixture of oil and water that are in the form of small droplets. Nanoemulsions can be created using different types of liquids, including oils, butters, and other fats. They are often used as ingredients in cosmetics and skin care products because they offer some benefits over traditional liquid formulations, such as being more lightweight and less greasy.
Some of the major companies in the nanoemulsion market are Allergan plc, AbbVie Inc., AstraZeneca Inc., Fresenius Kabi AG, Kaken Pharmaceutical Co., Ltd., GlaxoSmithKline plc, Novartis AG, Sanofi, B. Braun Melsungen AG..
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nanoemulsion Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Nanoemulsion Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Nanoemulsion Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Nanoemulsion Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Nanoemulsion Market Size & Forecast, 2018-2028
4.5.1 Nanoemulsion Market Size and Y-o-Y Growth
4.5.2 Nanoemulsion Market Absolute $ Opportunity
Chapter 5 Global Nanoemulsion Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Nanoemulsion Market Size Forecast by Type
5.2.1 Steroids
5.2.2 Anesthetics
5.2.3 NSAIDs
5.2.4 Immunosuppressant
5.2.5 Antiretroviral
5.2.6 Antimicrobials
5.2.7 Vasodilators
5.2.8 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Nanoemulsion Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Nanoemulsion Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 E-commerce
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nanoemulsion Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nanoemulsion Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Nanoemulsion Analysis and Forecast
9.1 Introduction
9.2 North America Nanoemulsion Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Nanoemulsion Market Size Forecast by Type
9.6.1 Steroids
9.6.2 Anesthetics
9.6.3 NSAIDs
9.6.4 Immunosuppressant
9.6.5 Antiretroviral
9.6.6 Antimicrobials
9.6.7 Vasodilators
9.6.8 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Nanoemulsion Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 E-commerce
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Nanoemulsion Analysis and Forecast
10.1 Introduction
10.2 Europe Nanoemulsion Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Nanoemulsion Market Size Forecast by Type
10.6.1 Steroids
10.6.2 Anesthetics
10.6.3 NSAIDs
10.6.4 Immunosuppressant
10.6.5 Antiretroviral
10.6.6 Antimicrobials
10.6.7 Vasodilators
10.6.8 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Nanoemulsion Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 E-commerce
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Nanoemulsion Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Nanoemulsion Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Nanoemulsion Market Size Forecast by Type
11.6.1 Steroids
11.6.2 Anesthetics
11.6.3 NSAIDs
11.6.4 Immunosuppressant
11.6.5 Antiretroviral
11.6.6 Antimicrobials
11.6.7 Vasodilators
11.6.8 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Nanoemulsion Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 E-commerce
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Nanoemulsion Analysis and Forecast
12.1 Introduction
12.2 Latin America Nanoemulsion Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Nanoemulsion Market Size Forecast by Type
12.6.1 Steroids
12.6.2 Anesthetics
12.6.3 NSAIDs
12.6.4 Immunosuppressant
12.6.5 Antiretroviral
12.6.6 Antimicrobials
12.6.7 Vasodilators
12.6.8 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Nanoemulsion Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 E-commerce
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Nanoemulsion Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Nanoemulsion Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Nanoemulsion Market Size Forecast by Type
13.6.1 Steroids
13.6.2 Anesthetics
13.6.3 NSAIDs
13.6.4 Immunosuppressant
13.6.5 Antiretroviral
13.6.6 Antimicrobials
13.6.7 Vasodilators
13.6.8 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Nanoemulsion Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 E-commerce
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nanoemulsion Market: Competitive Dashboard
14.2 Global Nanoemulsion Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allergan plc
14.3.2 AbbVie Inc.
14.3.3 AstraZeneca Inc.
14.3.4 Fresenius Kabi AG
14.3.5 Kaken Pharmaceutical Co., Ltd.
14.3.6 GlaxoSmithKline plc
14.3.7 Novartis AG
14.3.8 Sanofi
14.3.9 B. Braun Melsungen AG.
